Free Oncology CME 2017‑2018 | CMEList.com

 


Risky Business: Diagnosing and Treating Invasive Fungal Infections
Free Fungal Infection CME Posted by...Bernard Sklar, MD.
Free CME Credit Hours...1.0.
CME Credits Awarded by...Vindico Medical Education.
Cost for Credit...Free.
Instruction Type...Slide-Video Lectures.
Target Audience...Hematologist-oncologists, medical oncologists, transplant surgeons, critical care surgeons, critical care pulmonologists, and other health care professionals involved in the treatment of patients with or at risk for invasive fungal infections.
Educational material last updated...April 18, 2017.
CME Credit Expires...April 17, 2018.
Financial Support...Astellas.
Risky Business: Diagnosing and Treating Invasive Fungal Infections consists of 3 brief lectures on the diagnosis and treatment of invasive fungal infection:
After completing Risky Business: Diagnosing and Treating Invasive Fungal Infections, you should be better able to:
• Describe the epidemiology and burden of invasive fungal infections in patients who are immunocompromised and/or Immunosuppressed.
• Incorporate the latest diagnostic techniques for invasive fungal infections to ensure that the appropriate therapy can be initiated in a timely manner.
• Integrate the latest evidence-based treatment guidelines and clinical data pertaining to the efficacy, safety, and prophylactic use of antifungal agents to optimize the management of invasive fungal infections.

High Suspicion of Lung Cancer: Setting the Stage with a Good Biopsy Free Lung Cancer CME
Posted by...Bernard Sklar, MD.
Free Pulmonology CME Credit hours...0.5. 
CME Credits Awarded by....The France Foundation
Cost...........Free.
Instruction Type...Slide-Video Lecture.
Target Audiences...This program is intended for pulmonologists, critical care clinicians and other healthcare professionals involved in the management of patients with NSCLC.
Educational material updated....November 18, 2016.
Expiration of CME credit...November 17, 2017.
Financial Support...Bristol-Myers Squibb.
Dr. Momen Wahidi and Dr. W. Dean Wallace discuss how molecular diagnostics and targeted therapy rely on adequate tissue biopsy.
Upon completion of High Suspicion of Lung Cancer: Setting the Stage with a Good Biopsy, you should be able to:
• Identify key aspects of current guidance pertaining to adequate tissue acquisition and its implications in NSCLC
• Recognize the importance of obtaining adequate tissue samples for NSCLC diagnosis and classification, including molecular analysis

Work-Up of a Patient with Right Upper Lobe Mass and Metastases Free Lung Cancer CME
Posted by...Bernard Sklar, MD.
Free Pulmonology CME Credit hours...0.5. 
CME Credits Awarded by....The France Foundation.
Cost...........Free.
Instruction Type...Slide-Video Lecture.
Target Audiences...This program is intended for pulmonologists, critical care clinicians and other healthcare professionals involved in the management of patients with NSCLC.
Educational material updated....November 18, 2016.
Expiration of CME credit...November 17, 2017.
Financial Support...Bristol-Myers Squibb.
W. Dean Wallace, MD and Dr. Momen Wahidi discuss tissue processing and analysis from the pathology perspective.
Upon completion of Work-Up of a Patient with Right Upper Lobe Mass and Metastases, you should be able to:
• Identify key aspects of current guidance pertaining to adequate tissue acquisition and its implications in NSCLC
• Recognize the importance of obtaining adequate tissue samples for NSCLC diagnosis and classification, including molecular analysis

New Horizons in the Management of Metastatic Pancreatic Cancer
Free Pancreatic Cancer CME Live online February 15, 2017, and available on demand through August 15, 2017.
Posted by...Bernard Sklar, MD.
Free Oncology CME Credit hours...1.0.
CME Credits Awarded by....Postgraduate Institute for Medicine.
Cost...........Free.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...This program is intended for medical oncologists, gastroenterologists, and other health care professionals (primary care physicians, physicians-in-training, oncology nurses, nurse practitioners, pharmacists, physician assistants, etc.) involved or interested in the management of patients with pancreatic cancer.
Educational material updated... February 15, 2017.
Expiration of CME credit...August 15, 2017.
Financial Support...Incyte Corporation.
This activity consists of a single lecture, New Horizons in the Management of Metastatic Pancreatic Cancer, with discussion. At the conclusion of New Horizons in the Management of Metastatic Pancreatic Cancer, you will be able to:
• Examine the safety and efficacy data of emerging and available treatment options for patients with metastatic pancreatic cancer
• Evaluate and select optimal treatment algorithms for patients with metastatic pancreatic cancer

Metastatic Colorectal Cancer: Decoding Complex Treatment Algorithms through Debates and Cases Free Colorectal Cancer CME
This presentation is in two parts: The first part, Treatment Controversies in Metastatic Colorectal Cancer, live online December 16, 2016, and available on demand through July 31, 2017.
The second part, Examining Clinical Cases in Metastatic Colorectal Cancer, live online January 31, 2017, and available on demand through July 31, 2017.
Posted by...Bernard Sklar, MD.
Free Oncology CME Credit hours...2.0. 
CME Credits Awarded by....University of Nebraska Medical Center.
Cost...........Free.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...This program is intended for medical oncologists and other health care professionals (physicians, physicians-in-training, oncology nurses, nurse practitioners, pharmacists, physician assistants, etc.) involved or interested in the therapeutic management of patients with metastatic colorectal cancer (CRC).
Educational material updated....December 16, 2016.
Expiration of CME credit...July 31, 2017.
Financial Support...Genentech, Inc., Taiho Oncology, Inc, and Lilly.
Financial Support...Merck.
After viewing Metastatic Colorectal Cancer,  you will be better able to:
• Examine the latest safety and efficacy data of available treatments in the first, second, and beyond lines for metastatic CRC
• Compare the benefits and challenges among available CRC treatments in first-, second-, and third-line settings
• Summarize the key results from the abstracts presented at the 2017 Gastrointestinal Cancers Symposium (ASCO GI)
• Evaluate and select optimal treatment algorithms for patients with metastatic CRC
• Appraise the emerging application of immunotherapy for metastatic CRC

Myeloproliferative Disorders: Improving Outcomes for Patients with Myeloproliferative Disorders Free Myeloproliferative Disorders CME
Live online October 27, 2016, and available on demand through October 27, 2017.
Posted by...Bernard Sklar, MD.
Free Oncology CME Credit hours...2.0.
CME Credits Awarded by....Postgraduate Institute for Medicine.
Cost...........Free.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...This program is intended for hematologists, medical oncologists, oncology nurses, pharmacists, and other clinicians involved in the diagnosis and treatment of chronic myeloid leukemia (CML) and myeloproliferative neoplasms.
Educational material updated... October 27, 2016.
Expiration of CME credit...October 27, 2017.
Financial Support...Incyte Corporation.
Improving Outcomes for Patients with Myeloproliferative Disorders consists of two lectures:
• Updates in Chronic Phase Chronic Myeloid Leukemia; and
• Addressing The Challenges in Myeloproliferative Neoplasms
After viewing these two presentations you will be better able to:
• Implement evidence-based recommendations for molecular profiling, monitoring of treatment response, and managing tyrosine kinase inhibitor resistance.
• Employ new data on the safety and efficacy of current and emerging agents and combinations, mechanisms of action, molecular targets, and routes of administration to improve CML patient outcomes.

Virtual Prostate Summit: Evolving Treatment Paradigms in Metastatic Castration-Resistant Prostate Cancer Prostate Cancer CME
Live online July 27, 2016, and available on demand through July 27, 2017.
Posted by...Bernard Sklar, MD.
Free Prostate Cancer CME Credit hours...2.0.
CME Credits Awarded by....Albert Einstein College of Medicine.
Cost...........Free.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...This program is intended for medical oncologists, urologists, and health care professionals involved in the management of patients with prostate cancer, including those with metastatic castration-resistant prostate cancer.
Educational material updated... July 27, 2016.
Expiration of CME credit... July 27, 2017.
Financial Support...Sanofi US.
Evolving Treatment Paradigms in Metastatic Castration-Resistant Prostate Cancer consists of two lectures:
• Management of Metastatic Prostate Cancer - Non-Androgen Receptor-Targeted Therapies
• Androgen Receptor-Targeted Therapies - Metastatic Castration-resistant Prostate Cancer
At the conclusion of Evolving Treatment Paradigms in Metastatic Castration-Resistant Prostate Cancer, you will be able to:
• Address barriers to the optimal use of new therapies in patients with prostate cancer
• Evaluate relative safety, efficacy, and tolerability on therapeutic options for prostate cancer and potential sequencing combinations for those patients with suboptimal responses
• Identify and assess relative safety, efficacy, and tolerability on therapeutic options for metastatic castration-resistant prostate cancer

ScientiaCME Hematology/ Oncology  ScientiaCME Oncology  
Posted by...Bernard Sklar, MD.
Free Oncology CME Credit Hours...7.25.
CME Credits Awarded by....ScientiaCME.
Cost...........Free.
Instruction Type...Slide-Video Lectures.
Target Audience...HEMATOLOGY.
CME Credit Expires...Two years after release.
Financial Support...Various commercial supporters.

HER2+ BRCA INSTANT SYMPOSIUM: Updates on HER2 Positive Breast Cancer Management Free Breast Cancer CME
Live online June 10, 2016, and available on demand through June 10, 2017.
Posted by...Bernard Sklar, MD.
Free Breast Cancer CME Credit hours...1.0.
CME Credits Awarded by....Albert Einstein College of Medicine.
Cost...........Free.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...This program is intended for oncologists, hematologist-oncologists, radiation oncologists, breast surgeons, oncology nurse practitioners, pharmacists, and other healthcare professionals who treat patients with breast cancer.
Educational material updated...June 10, 2016.
Expiration of CME credit...June 10, 2017.
Financial Support...Genentech.
Updates on HER2 Positive Breast Cancer Management consists of a single lecture with discussion:
Updates on HER2 Positive Breast Cancer Management
At the conclusion of Updates on HER2 Positive Breast Cancer Management, you will be able to:
• Summarize the efficacy and safety of new and emerging treatment approaches for HER2 positive breast cancer in the neoadjuvant, adjuvant and metastatic settings
• Evaluate therapeutic challenges associated with HER2-targeted treatment, including resistance, toxicity and optimal duration of treatment